REGENXBIO Reports First Quarter 2026 Financial Results and Operational Highlights
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
- Nasdaq reaches record high close, AI stocks rally
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
Regenxbio (RGNX) Misses Q1 EPS by 38c, Misses on Revenue
May 14, 2026 7:12 AM EDTRegenxbio (NASDAQ: RGNX) reported Q1 EPS of ($1.72), $0.38 worse than the analyst estimate of ($1.34). Revenue for the quarter came in at $6.39 million versus the consensus estimate of $25.8 million.
For earnings history and earnings-related data on Regenxbio (RGNX) click here.
... More